Community Science Liaison Fellowship
End the Legacy is proud to support those in solidarity with the genetic or inherited ALS and FTD community who are in late research/medical training or early in a career related to genetic or inherited ALS and FTD with the establishment of the Community Science Liaison Fellowship. This fellowship will provide up to $5,000 a year for travel and costs related to research conference attendance. The awardee will be expected to provide lay summaries of things of note that were learned at the events and to represent the interests of the genetic or inherited ALS and FTD community at such events when appropriate.
Our First Community Science Liaison Fellow - Yentli Soto Albrecht, PhD
Yentli Soto Albrecht is an 8th-year MD-PhD student at the University of Pennsylvania. She
completed her PhD (2024) in the Douglas Wallace lab at the Children's Hospital of Philadelphia, discovering how mitochondrial function restricts SARS-CoV-2 replication and that natural mitochondrial DNA variation modulates viral pathogenesis, earning the Richard K. Root Prize (2025). She served as American Physician Scientists Association (APSA) President (2022-2023), managing a $300,000+ budget and reaching 5,000+ dual degree applicants nationally during her five-year APSA tenure.
Following her father's death from C9orf72 ALS in August 2024, and as a carrier of the same variant, she pivoted to neurodegeneration research. In 6 months, she developed six collaborative C9orf72 projects and is launching the first commercial C9orf72 iPSC biorepository through End the Legacy. Dr. Soto Albrecht leverages her triple perspective—genetic carrier, scientist, and physician-in-training—to accelerate therapeutic development for familial ALS/FTD.
Questions?
To inquire more about the program email info@endthelegacy.org